Immunogenicity of two‐dose sinopharm BBIB‐CorV vaccine in Morocco: One‐year follow‐up and neutralizing activity against severe acute respiratory syndrome coronavirus 2 variants of concern
The immunogenic response to the newly emerging SARS-CoV-2 variants of concern (VOCs), such as Delta and Omicron was comparatively reduced. As a result, it is recommended that additional boost vaccinations be considered.
Authors
- Hamza Ghammaz
- Mostafa Elouennass (ORCID: https://orcid.org/0000-0003-2944-6148)
- Khalid Ennibi
- Karim El Bakkouri (ORCID: https://orcid.org/0000-0001-9102-9877)
- Omar Nyabi (ORCID: https://orcid.org/0000-0003-0479-4103)
- Lamiae Belayachi (ORCID: https://orcid.org/0009-0002-0389-5260)
- Maha Ouarab (ORCID: https://orcid.org/0009-0002-9385-9588)
- Hicham El Annaz (ORCID: https://orcid.org/0000-0002-4551-6479)
- Nadia Touil (ORCID: https://orcid.org/0000-0003-4183-7758)
- Mouhssine Hemlali
- Elarbi Bouaiti
- Safae El Kochri
- Elmostafa El Fahime (ORCID: https://orcid.org/0000-0001-7812-0641)
- Zineb Rhazzar
- Jean Luc Gala
Institutions
- Mohammed V University (MA)
- Centre National pour la Recherche Scientifique et Technique (CNRST) (MA)
- National Centre for Nuclear Energy, Science and Technology (MA)
- International University of Rabat (MA)
- Université Mohammed VI des Sciences et de la Santé (MA)
- UCLouvain (BE)
- University of Hassan II Casablanca (MA)
Publication Details
- Journal
- Immunity Inflammation and Disease
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1002/iid3.1359
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39